Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.1.1 POLITICAL FACTORS
4.1.2 ECONOMIC FACTORS
4.1.3 SOCIAL FACTORS
4.1.4 TECHNOLOGICAL FACTORS
4.1.5 LEGAL FACTORS
4.1.6 ENVIRONMENTAL FACTORS
4.2 PORTER’S FIVE FORCES
4.2.1 THREAT OF NEW ENTRANTS
4.2.2 BARGAINING POWER OF SUPPLIERS
4.2.3 BARGAINING POWER OF BUYERS
4.2.4 THREAT OF SUBSTITUTES
4.2.5 COMPETITIVE RIVALRY
4.3 INNOVATION STRATEGIES
4.3.1 KEY INNOVATION STRATEGIES
4.3.2 EMERGING DELIVERY TECHNIQUES
4.3.3 STRATEGIC IMPLICATIONS
4.3.4 CONCLUSION
4.4 INNOVATION STRATEGIES
4.4.1 KEY INNOVATION STRATEGIES
4.4.2 EMERGING DELIVERY TECHNIQUES
4.4.3 STRATEGIC IMPLICATIONS
4.4.4 CONCLUSION
4.5 SUPPLY CHAIN ANALYSIS
4.5.1 OVERVIEW
4.5.2 RAW MATERIAL AVAILABILITY
4.5.3 MANUFACTURING CAPACITY
4.5.4 LOGISTICS AND LAST-MILE HURDLES
4.5.5 PRICING MODELS AND MARKET POSITIONING
4.6 RISK AND MITIGATION
4.7 VENDOR SELECTION DYNAMICS
4.7.1 PRODUCT QUALITY AND REGULATORY EXCELLENCE
4.7.2 PLASMA SUPPLY SECURITY AND SUPPLY CHAIN RESILIENCE
4.7.3 CLINICAL PERFORMANCE, INDICATION BREADTH, AND INNOVATION
4.7.4 COST STRUCTURE, CONTRACT FLEXIBILITY, AND REIMBURSEMENT ALIGNMENT
4.7.5 GEOGRAPHIC FOOTPRINT AND LOCAL MARKET SUPPORT
4.7.6 ETHICAL PLASMA SOURCING, ESG COMMITMENTS, AND TRANSPARENCY
4.7.7 STRATEGIC PARTNERSHIPS AND LONG-TERM VALUE CREATION
4.7.8 CONCLUSION
5 TARIFFS & IMPACT ON THE MARKET
5.1 CURRENT TARIFF RATES IN TOP-5 COUNTRY MARKETS
5.2 OUTLOOK: LOCAL PRODUCTION VS. IMPORT RELIANCE
5.3 VENDOR SELECTION CRITERIA DYNAMICS
5.4 IMPACT ON SUPPLY CHAIN
5.4.1 PLASMA COLLECTION & RAW MATERIAL AVAILABILITY
5.4.2 MANUFACTURING AND FRACTIONATION
5.4.3 LOGISTICS AND DISTRIBUTION
5.4.4 PRICING AND MARKET POSITIONING
5.5 INDUSTRY PARTICIPANTS: PROACTIVE MOVES
5.5.1 SUPPLY CHAIN OPTIMIZATION
5.5.2 STRATEGIC PARTNERSHIPS & JOINT VENTURES
5.6 IMPACT ON PRICES
5.7 REGULATORY INCLINATION
5.7.1 GCC TRADE ALIGNMENT & FTAS
5.7.2 SPECIAL ZONES AND RE-EXPORT MODELS
5.7.3 LOCAL SUBSIDY & POLICY RESPONSE
5.7.4 DOMESTIC COURSE OF CORRECTION
6 REGULATION COVERAGE
7 MARKET OVERVIEW
7.1 DRIVER
7.1.1 RISING PREVALENCE OF RARE AND CHRONIC DISEASES
7.1.2 EXPANDING GERIATRIC POPULATION
7.1.3 TECHNOLOGICAL ADVANCEMENTS IN PLASMA FRACTIONATION
7.1.4 GOVERNMENT AND INSTITUTIONAL SUPPORT
7.2 RESTRAINTS
7.2.1 HIGH COST AND COMPLEX MANUFACTURING PROCESS
7.2.2 LACK OF PLASMA SUPPLY AND DONOR
7.3 OPPORTUNITIES
7.3.1 ADVANCEMENTS IN PLASMA PROCESSING TECHNOLOGIES TO ENHANCE YIELD AND REDUCE COSTS
7.3.2 REIMBURSEMENT FRAMEWORKS AND INCREASED GOVERNMENTAL FOCUS ON RARE DISEASE TREATMENT
7.3.3 STRATEGIC ALLIANCES, MERGERS, AND ACQUISITIONS TO STRENGTHEN ASIA-PACIFIC MARKET PENETRATION
7.4 CHALLENGES
7.4.1 COMPETITIVE PRESSURE FROM RECOMBINANT AND ALTERNATIVE BIOLOGICAL THERAPIES
7.4.2 INFRASTRUCTURE LIMITATIONS IN COLD CHAIN LOGISTICS IMPACTING PRODUCT DISTRIBUTION
8 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 IMMUNOGLOBULINS
8.3 COAGULATION FACTORS
8.4 ALBUMIN
8.5 PROTEASE INHIBITORS
8.6 MONOCLONAL ANTIBODIES
8.7 OTHER PLASMA DERIVED PROTEINS
8.8 ASIA-PACIFIC IMMUNOGLOBULINS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.8.1 NORTH AMERICA
8.8.2 EUROPE
8.8.3 ASIA-PACIFIC
8.8.4 SOUTH AMERICA
8.8.5 MIDDLE EAST AND AFRICA
8.9 ASIA-PACIFIC COAGULATION FACTORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.9.1 NORTH AMERICA
8.9.2 EUROPE
8.9.3 ASIA-PACIFIC
8.9.4 SOUTH AMERICA
8.9.5 MIDDLE EAST AND AFRICA
8.1 ASIA-PACIFIC ALBUMIN IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.10.1 NORTH AMERICA
8.10.2 EUROPE
8.10.3 ASIA-PACIFIC
8.10.4 SOUTH AMERICA
8.10.5 MIDDLE EAST AND AFRICA
8.11 ASIA-PACIFIC PROTEASE INHIBITORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.11.1 NORTH AMERICA
8.11.2 EUROPE
8.11.3 ASIA-PACIFIC
8.11.4 SOUTH AMERICA
8.11.5 MIDDLE EAST AND AFRICA
8.12 ASIA-PACIFIC MONOCLONAL ANTIBODIES IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.12.1 NORTH AMERICA
8.12.2 EUROPE
8.12.3 ASIA-PACIFIC
8.12.4 SOUTH AMERICA
8.12.5 MIDDLE EAST AND AFRICA
8.13 ASIA-PACIFIC OTHER PLASMA DERIVED PROTEINS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.13.1 NORTH AMERICA
8.13.2 EUROPE
8.13.3 ASIA-PACIFIC
8.13.4 SOUTH AMERICA
8.13.5 MIDDLE EAST AND AFRICA
9 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 IMMUNOLOGY
9.3 HAEMATOLOGY
9.4 CRITICAL CARE
9.5 NEUROLOGY
9.6 PULMONOLOGY
9.7 HAEMATO-ONCOLOGY
9.8 RHEUMATOLOGY
9.9 OTHER APPLICATIONS
9.1 ASIA-PACIFIC IMMUNOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.10.1 NORTH AMERICA
9.10.2 EUROPE
9.10.3 ASIA-PACIFIC
9.10.4 SOUTH AMERICA
9.10.5 MIDDLE EAST AND AFRICA
9.11 ASIA-PACIFIC HAEMATOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.11.1 NORTH AMERICA
9.11.2 EUROPE
9.11.3 ASIA-PACIFIC
9.11.4 SOUTH AMERICA
9.11.5 MIDDLE EAST AND AFRICA
9.12 ASIA-PACIFIC CRITICAL CARE IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.12.1 NORTH AMERICA
9.12.2 EUROPE
9.12.3 ASIA-PACIFIC
9.12.4 SOUTH AMERICA
9.12.5 MIDDLE EAST AND AFRICA
9.13 ASIA-PACIFIC NEUROLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.13.1 NORTH AMERICA
9.13.2 EUROPE
9.13.3 ASIA-PACIFIC
9.13.4 SOUTH AMERICA
9.13.5 MIDDLE EAST AND AFRICA
9.14 ASIA-PACIFIC PULMONOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.14.1 NORTH AMERICA
9.14.2 EUROPE
9.14.3 ASIA-PACIFIC
9.14.4 SOUTH AMERICA
9.14.5 MIDDLE EAST AND AFRICA
9.15 ASIA-PACIFIC HAEMATO-ONCOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.15.1 NORTH AMERICA
9.15.2 EUROPE
9.15.3 ASIA-PACIFIC
9.15.4 SOUTH AMERICA
9.15.5 MIDDLE EAST AND AFRICA
9.16 ASIA-PACIFIC RHEUMATOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.16.1 NORTH AMERICA
9.16.2 EUROPE
9.16.3 ASIA-PACIFIC
9.16.4 SOUTH AMERICA
9.16.5 MIDDLE EAST AND AFRICA
9.17 ASIA-PACIFIC OTHER APPLICATIONS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.17.1 NORTH AMERICA
9.17.2 EUROPE
9.17.3 ASIA-PACIFIC
9.17.4 SOUTH AMERICA
9.17.5 MIDDLE EAST AND AFRICA
10 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY
10.1 OVERVIEW
10.2 ION EXCHANGE CHROMATOGRAPHY
10.3 AFFINITY CHROMATOGRAPHY
10.4 CRYOPRECIPITATION
10.5 ULTRAFILTRATION
10.6 MICROFILTRATION
10.7 ASIA-PACIFIC ION EXCHANGE CHROMATOGRAPHY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.7.1 NORTH AMERICA
10.7.2 EUROPE
10.7.3 ASIA-PACIFIC
10.7.4 SOUTH AMERICA
10.7.5 MIDDLE EAST AND AFRICA
10.8 ASIA-PACIFIC AFFINITY CHROMATOGRAPHY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.8.1 NORTH AMERICA
10.8.2 EUROPE
10.8.3 ASIA-PACIFIC
10.8.4 SOUTH AMERICA
10.8.5 MIDDLE EAST AND AFRICA
10.9 ASIA-PACIFIC CRYOPRECIPITATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.9.1 NORTH AMERICA
10.9.2 EUROPE
10.9.3 ASIA-PACIFIC
10.9.4 SOUTH AMERICA
10.9.5 MIDDLE EAST AND AFRICA
10.1 ASIA-PACIFIC ULTRAFILTRATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.10.1 NORTH AMERICA
10.10.2 EUROPE
10.10.3 ASIA-PACIFIC
10.10.4 SOUTH AMERICA
10.10.5 MIDDLE EAST AND AFRICA
10.11 ASIA-PACIFIC MICROFILTRATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.11.1 NORTH AMERICA
10.11.2 EUROPE
10.11.3 ASIA-PACIFIC
10.11.4 SOUTH AMERICA
10.11.5 MIDDLE EAST AND AFRICA
11 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE
11.1 OVERVIEW
11.2 MODERN
11.3 TRADITIONAL PLASMA FRACTIONATION
11.4 ASIA-PACIFIC MODERN IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.4.1 NORTH AMERICA
11.4.2 EUROPE
11.4.3 ASIA-PACIFIC
11.4.4 SOUTH AMERICA
11.4.5 MIDDLE EAST AND AFRICA
11.5 ASIA-PACIFIC TRADITIONAL PLASMA FRACTIONATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.5.1 NORTH AMERICA
11.5.2 EUROPE
11.5.3 ASIA-PACIFIC
11.5.4 SOUTH AMERICA
11.5.5 MIDDLE EAST AND AFRICA
12 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS & CLINICS
12.3 RESEARCH LABS
12.4 ACADEMIC INSTITUTES
12.5 OTHERS
12.6 ASIA-PACIFIC HOSPITALS & CLINICS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.6.1 NORTH AMERICA
12.6.2 EUROPE
12.6.3 ASIA-PACIFIC
12.6.4 SOUTH AMERICA
12.6.5 MIDDLE EAST AND AFRICA
12.7 ASIA-PACIFIC RESEARCH LABS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.7.1 NORTH AMERICA
12.7.2 EUROPE
12.7.3 ASIA-PACIFIC
12.7.4 SOUTH AMERICA
12.7.5 MIDDLE EAST AND AFRICA
12.8 ASIA-PACIFIC ACADEMIC INSTITUTES IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.8.1 NORTH AMERICA
12.8.2 EUROPE
12.8.3 ASIA-PACIFIC
12.8.4 SOUTH AMERICA
12.8.5 MIDDLE EAST AND AFRICA
12.9 ASIA-PACIFIC OTHERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.9.1 NORTH AMERICA
12.9.2 EUROPE
12.9.3 ASIA-PACIFIC
12.9.4 SOUTH AMERICA
12.9.5 MIDDLE EAST AND AFRICA
13 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDERS
13.3 THIRD PARTY DISTRIBUTORS
13.4 OTHERS
13.5 ASIA-PACIFIC DIRECT TENDERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.5.1 NORTH AMERICA
13.5.2 EUROPE
13.5.3 ASIA-PACIFIC
13.5.4 SOUTH AMERICA
13.5.5 MIDDLE EAST AND AFRICA
13.6 ASIA-PACIFIC THIRD PARTY DISTRIBUTORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.6.1 NORTH AMERICA
13.6.2 EUROPE
13.6.3 ASIA-PACIFIC
13.6.4 SOUTH AMERICA
13.6.5 MIDDLE EAST AND AFRICA
13.7 ASIA-PACIFIC OTHERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.7.1 NORTH AMERICA
13.7.2 EUROPE
13.7.3 ASIA-PACIFIC
13.7.4 SOUTH AMERICA
13.7.5 MIDDLE EAST AND AFRICA
14 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION
14.1 ASIA-PACIFIC
14.1.1 CHINA
14.1.2 JAPAN
14.1.3 SOUTH KOREA
14.1.4 AUSTRALIA
14.1.5 INDIA
14.1.6 MALAYSIA
14.1.7 THAILAND
14.1.8 SINGAPORE
14.1.9 PHILIPPINES
14.1.10 INDONESIA
14.1.11 NEW ZEALAND
14.1.12 VIETNAM
14.1.13 TAIWAN
14.1.14 REST OF ASIA-PACIFIC
15 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 CSL
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 TAKEDA PHARMACEUTICAL COMPANY LIMITED
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 GRIFOLS, S.A.
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 OCTAPHARMA AG
17.4.1 COMPANY SNAPSHOT
17.4.2 COMPANY SHARE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENT
17.5 KEDRION
17.5.1 COMPANY SNAPSHOT
17.5.2 COMPANY SHARE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENT
17.6 ADMA BIOLOGICS, INC
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 AEGROS
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENT
17.8 BHARAT SERUMS
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 BIOTEST AG.
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 FRESENIUS KABI AG
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 GC BIOPHARMA CORPORATE
17.11.1 COMPANY SNAPSHOT
17.11.2 REVENUE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENT
17.12 ICHOR
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 INTAS PHARMACEUTICALS LTD.
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 KAMADA PHARMACEUTICALS
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENT
17.15 KM BIOLOGICS
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 LFB
17.16.1 COMPANY SNAPSHOT
17.16.2 THERAPY PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 PLASMAGEN BIOSCIENCES PVT. LTD.
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 PROLIANT HEALTH & BIOLOGICALS
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 PROMEA
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 RELIANCE LIFE SCIENCES.
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
17.21 SICHUAN YUANDA SHYUANG PHARMACEUTICAL CO., LTD.
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 SK PLASMA
17.22.1 COMPANY SNAPSHOT
17.22.2 PRODUCT PORTFOLIO
17.22.3 RECENT DEVELOPMENT
17.23 SYNTHAVERSE S. A.
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENT
17.24 TAIBANG BIO GROUP CO., LTD
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENT
17.25 VIRCHOW BIOTECH
17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 2 ASIA-PACIFIC IMMUNOGLOBULINS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 3 ASIA-PACIFIC COAGULATION FACTORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 4 ASIA-PACIFIC ALBUMIN IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 5 ASIA-PACIFIC PROTEASE INHIBITORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 6 ASIA-PACIFIC MONOCLONAL ANTIBODIES IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 7 ASIA-PACIFIC OTHER PLASMA DERIVED PROTEINS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 8 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 9 ASIA-PACIFIC IMMUNOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 10 ASIA-PACIFIC HAEMATOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 11 ASIA-PACIFIC CRITICAL CARE IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 12 ASIA-PACIFIC NEUROLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 13 ASIA-PACIFIC PULMONOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 14 ASIA-PACIFIC HAEMATO-ONCOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 15 ASIA-PACIFIC RHEUMATOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 16 ASIA-PACIFIC OTHER APPLICATIONS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 17 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 18 ASIA-PACIFIC ION EXCHANGE CHROMATOGRAPHY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 19 ASIA-PACIFIC AFFINITY CHROMATOGRAPHY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 20 ASIA-PACIFIC CRYOPRECIPITATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 21 ASIA-PACIFIC ULTRAFILTRATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 22 ASIA-PACIFIC MICROFILTRATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 23 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 24 ASIA-PACIFIC MODERN IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 25 ASIA-PACIFIC TRADITIONAL PLASMA FRACTIONATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 26 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 27 ASIA-PACIFIC HOSPITALS & CLINICS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 28 ASIA-PACIFIC RESEARCH LABS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 29 ASIA-PACIFIC ACADEMIC INSTITUTES IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 30 ASIA-PACIFIC OTHERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 31 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 32 ASIA-PACIFIC DIRECT TENDERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 33 ASIA-PACIFIC THIRD PARTY DISTRIBUTORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 34 ASIA-PACIFIC OTHERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 35 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, 2018-2033 (USD THOUSAND)
TABLE 36 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 37 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 38 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 39 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 40 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 41 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 42 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 43 CHINA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 44 CHINA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 45 CHINA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 46 CHINA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 47 CHINA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 48 CHINA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 49 JAPAN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 50 JAPAN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 51 JAPAN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 52 JAPAN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 53 JAPAN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 54 JAPAN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 55 SOUTH KOREA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 56 SOUTH KOREA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 57 SOUTH KOREA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 58 SOUTH KOREA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 59 SOUTH KOREA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 60 SOUTH KOREA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 61 AUSTRALIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 62 AUSTRALIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 63 AUSTRALIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 64 AUSTRALIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 65 AUSTRALIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 66 AUSTRALIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 67 INDIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 68 INDIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 69 INDIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 70 INDIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 71 INDIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 72 INDIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 73 MALAYSIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 74 MALAYSIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 75 MALAYSIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 76 MALAYSIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 77 MALAYSIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 78 MALAYSIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 79 THAILAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 80 THAILAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 81 THAILAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 82 THAILAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 83 THAILAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 84 THAILAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 85 SINGAPORE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 86 SINGAPORE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 87 SINGAPORE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 88 SINGAPORE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 89 SINGAPORE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 90 SINGAPORE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 91 PHILIPPINES BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 92 PHILIPPINES BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 93 PHILIPPINES BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 94 PHILIPPINES BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 95 PHILIPPINES BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 96 PHILIPPINES BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 97 INDONESIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 98 INDONESIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 99 INDONESIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 100 INDONESIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 101 INDONESIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 102 INDONESIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 103 NEW ZEALAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 104 NEW ZEALAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 105 NEW ZEALAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 106 NEW ZEALAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 107 NEW ZEALAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 108 NEW ZEALAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 109 VIETNAM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 110 VIETNAM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 111 VIETNAM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 112 VIETNAM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 113 VIETNAM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 114 VIETNAM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 115 TAIWAN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 116 TAIWAN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 117 TAIWAN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 118 TAIWAN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 119 TAIWAN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 120 TAIWAN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 121 REST OF ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 122 REST OF ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 123 REST OF ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 124 REST OF ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 125 REST OF ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 126 REST OF ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
List of Figure
FIGURE 1 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: SEGMENTATION
FIGURE 11 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: EXECUTIVE SUMMARY
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 NORTH AMEIRCA IS EXPECTED TO DOMINATE THE MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 14 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT (2024)
FIGURE 15 RISING PREVELANCE OF RARE & CHRONIC DISEASES IS EXPECTED TO DRIVE THE ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, IN THE FORECAST PERIOD OF 2026 TO 2033
FIGURE 16 IMMUNOGLOBULINS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET IN THE FORECAST PERIOD OF 2026 & 2033
FIGURE 17 ASIA-PACIFIC IS THE FASTEST-GROWING REGION FOR ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET IN THE FORECAST PERIOD OF 2026 TO 2033
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES FOR THE ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET
FIGURE 19 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY PRODUCT, 2025
FIGURE 20 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY PRODUCT, 2026 TO 2033 (USD THOUSAND)
FIGURE 21 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY PRODUCT, CAGR (2026- 2033)
FIGURE 22 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 23 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY APPLICATION, 2025
FIGURE 24 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY APPLICATION, 2026 TO 2033 (USD THOUSAND)
FIGURE 25 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY APPLICATION, CAGR (2026- 2033)
FIGURE 26 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 27 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY TECHNOLOGY, 2025
FIGURE 28 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY TECHNOLOGY, 2026 TO 2033 (USD THOUSAND)
FIGURE 29 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY TECHNOLOGY, CAGR (2026- 2033)
FIGURE 30 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 31 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY MODE, 2025
FIGURE 32 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY MODE, 2026 TO 2033 (USD THOUSAND)
FIGURE 33 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY MODE, CAGR (2026- 2033)
FIGURE 34 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY MODE, LIFELINE CURVE
FIGURE 35 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY END USER, 2025
FIGURE 36 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY END USER, 2026 TO 2033 (USD THOUSAND)
FIGURE 37 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY END USER, CAGR (2026- 2033)
FIGURE 38 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 39 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2025
FIGURE 40 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2026 TO 2033 (USD THOUSAND)
FIGURE 41 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2026- 2033)
FIGURE 42 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 43 ASIA-PACIFIC BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: SNAPSHOT (2025)
FIGURE 44 ASIA-PACIFIC BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: COMPANY SHARE 2025 (%)
